PRA023 Demonstrated Efficacy and Favorable Safety as Induction Therapy for Moderately to Severely Active UC: Phase 2 ARTEMIS-UC Study Results-MedSci.cn

PRA023 Demonstrated Efficacy and Favorable Safety as Induction Therapy for Moderately to Severely Active UC: Phase 2 ARTEMIS-UC Study Results

Sands, B; Peyrin-Biroulet, L; Danese, S; Rubin, DT; Vermeire, S; Laurent, O; Luo, A; Nguyen, D; Lu, JD; Wiechowska-Kozlowska, A; Leszczyszyn, J; Kempinski, R; Kierkus, J; Ma, C; Ritter, T; Feagan, BG; Targan, S

JOURNAL OF CROHNS & COLITIS, 2023; 17 (): I56

科室
- - 订阅+
  - 更多科室
工具
服务